ProCE Banner Activity

Real-World Oral Antiviral Efficacy and COVID-19 Rebound

Multimedia
Hear expert insights on oral antiviral efficacy in real-world populations and COVID-19 rebound phenomenon.

Released: August 05, 2022

Expiration: August 04, 2023

Share

Faculty

Arthur Kim

Arthur Kim, MD

Associate Professor of Medicine
Harvard Medical School
Division of Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Arthur Kim, MD

Associate Professor of Medicine
Harvard Medical School
Division of Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts

Arthur Kim, MD: drug and safety monitoring board: Kintor.